Navigation Links
EarlySense's EverOn(TM) System Receives FDA Clearance and CE Mark Certification
Date:6/8/2009

RAMAT GAN, Israel, June 8 /PRNewswire/ -- EarlySense announced today that its EverOn contact-free patient supervision system has been cleared for marketing by the U.S. Food and Drug Administration and has received a CE Mark certification from KEMA, a Dutch notified body, in accordance with the EC-Directive 93/42/EEC. Both allow EverOn for use with children and adults, in a home, hospital or clinical setting. In November 2007, EarlySense announced the FDA clearance of the ES-16, the predecessor of the EverOn system.

EverOn is a wireless patient supervision system installed underneath a bed mattress. There are no leads or cuffs to connect to the patient. The system measures patient vital signs and movements and alerts nurses or caregivers of any change in condition. EverOn detects heart and respiration rates, bed entries and exits, as well as patient movement. EverOn also helps medical staff to better implement patient turns, which can positively influence the treatment and the prevention of pressure ulcers. EverOn's trend line display is designed to assist clinicians in monitoring the progression of a patient's health and support improved medical decision making.

"Today's FDA clearance and CE Mark news further validates our technology. There is an unquestioned need for a system that provides a virtual safety net for patients in hospitals and provides early warnings of physiological changes that may lead to patient deterioration. EverOn enables clinicians to intervene earlier and helps improve outcomes," said Mr. Avner Halperin, CEO of EarlySense.

EverOn's advanced sensing and software technology is currently being pre-market tested at leading hospitals and hospital networks in Israel, the U.S. and Europe. The market launch of the device is expected soon.

"Feedback from our principal investigators as well as the approval by the regulatory authorities indicate that the technology is effective, useful and unique in its deliverables. We strongly believe that EverOn will make a positive impact on the future of clinical practice and improve patient care both at the hospital and in post acute care settings," said Dalia Argaman, vice president of clinical and regulatory affairs at EarlySense.

About EarlySense:

EarlySense is bringing to market a pioneering technology designed to advance proactive and preventive patient supervision to enable better patient outcomes. EarlySense is headquartered in Ramat-Gan, Israel.

For additional information, please visit http://www.earlysense.com.

Press contact: Marjie Hadad, media liaison, at marjie.hadad@earlysense.com or at +972-54-536-5220.


'/>"/>
SOURCE EarlySense
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. First ASMS Hites Award for Outstanding Research Publication Presented to Prof. Alison Ashcroft for Her Use of Waters Synapt HDMS System to Explore Protein Complexes
2. Prometheus Research Signs 3-Year Contract With Simons Foundation to Expand HTSQL Informatics System for Autism Research
3. Delcath Systems Granted Third Orphan Drug Designation
4. Boston Scientifics SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R)
5. FDA Clears Boston Scientifics SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System
6. Penguin Computing Forms OEM Agreement with Applied Biosystems for Scyld ClusterWare
7. Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberte(R) Atom(TM) Stent system
8. FDA Approves Boston Scientifics Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
9. SANYO Donates Air Purification Systems Effective Against Flu Viruses to New York Airports and Schools
10. Dealzer Hydroponics Introduces the Super-File Cabinet Grow Box System
11. Smith & Nephew Endoscopy Launches the BICEPTOR(TM) Tenodesis System, the First All-Arthroscopic Procedure for Biceps Tendon Repair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017   Biostage, Inc. (Nasdaq: ... developing bioengineered organ implants to treat cancers and other ... today the closing on February 15, 2017 of its ... stock and warrants to purchase 20,000,000 shares of common ... offering was priced at $0.40 per share of common ...
(Date:2/16/2017)... ... February 16, 2017 , ... ... Dr. Kingsley Chin, professor and Harvard trained surgeon, completed the procedure on Monday, ... on a 55-year-old practicing female physician suffering from degenerative disc disease with radiculomyelopathy, ...
(Date:2/15/2017)... ... , ... Executive search firm, Slone Partners, announces the placement ... is a veteran life sciences and molecular diagnostics executive with extensive commercialization experience. ... disease risk in future generations. In his new role, Matt will be responsible ...
(Date:2/15/2017)... WARRINGTON, Pa. , Feb. 15, 2017 /PRNewswire/ ... ), a biotechnology company focused on developing aerosolized ... that it has completed a $10.5 million private ... expects that it has sufficient capital to fund ... 2b clinical trial data release in mid-2017. ...
Breaking Biology Technology:
(Date:1/25/2017)... 25, 2017 The Elements of Enterprise Information ... is comprised of a comprehensive set of business ... maintaining digital identities and providing a secured and ... are significant number of programs opted by enterprises ... by optimizing processes and changing policies. However, there ...
(Date:1/21/2017)... Research and Markets has announced the addition of the ... ... voice recognition biometrics market to grow at a CAGR of 19.36% ... present scenario and the growth prospects of the global voice recognition ... considers the revenue generated from the sales of voice recognition biometrics ...
(Date:1/18/2017)... , Jan. 18, 2017 ... company that supports the entire spectrum of clinical ... been another record-breaking year for the organization in ... interest in MedNet,s eClinical products and services. The ... tremendous marketplace success of iMedNet ...
Breaking Biology News(10 mins):